NewsBenzingaUPDATE: Edwards Lifesciences Raises FY2026 Adj EPS Guidance from $2.95-$3.05 to $2.97-$3.05 vs $3.00 Est; Narrows FY2026 Sales Guidance from $6.600B-$6.900B to $6.766B vs $6.767B Est UPDATE: Edwards Lifesciences Raises FY2026 Adj EPS Guidance from $2.95-$3.05 to $2.97-$3.05 vs $3.00 Est; Narrows FY2026 Sales Guidance from $6.600B-$6.900B to $6.766B vs $6.767B Est Benzinga 2026.11.04 21:21 (GMT+0) Open on Benzinga Other news CORRECTION: U-Haul Holding Q2 EPS $0.66 Misses $0.79 Estimate, Sales $1.727B Miss $1.789B Estimate UBS Maintains Buy on EMCOR Group, Lowers Price Target to $925 UBS Maintains Buy on Dynatrace, Lowers Price Target to $75 UBS Maintains Neutral on Chemours, Lowers Price Target to $15 If You Invested $1000 In Itau Unibanco Holding Stock 5 Years Ago, You Would Have This Much Today UBS Maintains Neutral on Cabot, Lowers Price Target to $80
